Clinical High Risk for Psychosis Overview

This 60-minute webinar provides an overview of clinical high risk (CHR-P) for psychosis and CHR-P programs. Dr. Jason Schiffman, Director of the PREVENT Lab at the University of California, Irvine provides an overview of CHR-P and moderates a panel composed of SAMHSA clinical high risk for psychosis grantees to discuss their experiences and challenges with program implementation as well as practical solutions and resources to advance clinical high risk for psychosis programming.